Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

The natural history of cervical cancer in chinese women: results from an 11-year follow-up study in china using a multistate model.

Zhang SK, Kang LN, Chang IJ, Zhao FH, Hu SY, Chen W, Shi JF, Zhang X, Pan QJ, Li SM, Qiao YL.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1298-305. doi: 10.1158/1055-9965.EPI-13-0846. Epub 2014 Apr 30.

2.
3.

[A prospective study on the prognosis of biopsy-confirmed cervical intraepithelial neoplasia grade 1 and the relationship with high-risk human papillomavirus].

Hu S, Zhao F, Ma J, Wang X, Han J, Li A, Chen F, Zhang X, Pan Q, Qiao Y.

Zhonghua Yu Fang Yi Xue Za Zhi. 2014 May;48(5):361-5. Chinese.

PMID:
24985373
4.

Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models.

Syrjänen K, Shabalova I, Sarian L, Naud P, Longatto-Filho A, Derchain S, Kozachenko V, Zakharchenko S, Roteli-Martins C, Nerovjna R, Kljukina L, Tatti S, Branovskaja M, Branca M, Grunjberga V, Erzen M, Juschenko A, Serpa Hammes L, Podistov J, Costa S, Syrjänen S; NIS Study Research Group; LAMS Study Research Group.

Eur J Gynaecol Oncol. 2012;33(1):5-14.

PMID:
22439398
5.

Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.

Heselmeyer-Haddad K, Sommerfeld K, White NM, Chaudhri N, Morrison LE, Palanisamy N, Wang ZY, Auer G, Steinberg W, Ried T.

Am J Pathol. 2005 Apr;166(4):1229-38.

6.

HLA class II DRB1*1302 allele protects against progression to cervical intraepithelial neoplasia grade 3: a multicenter prospective cohort study.

Matsumoto K, Maeda H, Oki A, Takatsuka N, Yasugi T, Furuta R, Hirata R, Mitsuhashi A, Fujii T, Hirai Y, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T, Yoshikawa H; for Japan HPV And Cervical Cancer (JHACC) Study Group.

Int J Gynecol Cancer. 2012 Mar;22(3):471-8. doi: 10.1097/IGC.0b013e3182439500.

PMID:
22391763
7.

Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses.

Wang SM, Colombara D, Shi JF, Zhao FH, Li J, Chen F, Chen W, Li SM, Zhang X, Pan QJ, Belinson JL, Smith JS, Qiao YL.

Int J Gynecol Cancer. 2013 May;23(4):716-23. doi: 10.1097/IGC.0b013e318286a95d.

8.

Analysis of the effectiveness of visual inspection with acetic acid/Lugol's iodine in one-time and annual follow-up screening in rural China.

Li R, Lewkowitz AK, Zhao FH, Zhou Q, Hu SY, Qiu H, Zhang Y, Jiang HW, Zhang JS, Li M, Tong SM, Zhang QY, Qiao YL.

Arch Gynecol Obstet. 2012 Jun;285(6):1627-32. doi: 10.1007/s00404-011-2203-4. Epub 2012 Jan 6.

PMID:
22222723
9.

Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.

Wang SS, Zuna RE, Wentzensen N, Dunn ST, Sherman ME, Gold MA, Schiffman M, Wacholder S, Allen RA, Block I, Downing K, Jeronimo J, Carreon JD, Safaeian M, Brown D, Walker JL.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):113-20. doi: 10.1158/1055-9965.EPI-08-0591.

10.

Follow-up study of patients with cervical intraepithelial neoplasia grade 1 overexpressing p16Ink4a.

Cortecchia S, Galanti G, Sgadari C, Costa S, De Lillo M, Caprara L, Barillari G, Monini P, Nannini R, Ensoli B, Bucchi L.

Int J Gynecol Cancer. 2013 Nov;23(9):1663-9. doi: 10.1097/IGC.0b013e3182a80b14.

PMID:
24172101
11.

Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.

Almog B, Gamzu R, Kuperminc MJ, Levin I, Fainaru O, Niv J, Bar-Am A.

Gynecol Oncol. 2003 Mar;88(3):345-50.

PMID:
12648585
12.

Differential DNA copy number aberrations in the progression of cervical lesions to invasive cervical carcinoma.

Oh EK, Kim YW, Kim IW, Liu HB, Lee KH, Chun HJ, Park DC, Oh EJ, Lee AW, Bae SM, Ahn WS.

Int J Oncol. 2012 Dec;41(6):2038-46. doi: 10.3892/ijo.2012.1644. Epub 2012 Sep 27.

PMID:
23023522
13.

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.

McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC.

Lancet Oncol. 2008 May;9(5):425-34. doi: 10.1016/S1470-2045(08)70103-7. Epub 2008 Apr 11.

PMID:
18407790
14.

Cervical intraepithelial neoplasia grade 3 lesions can regress.

Munk AC, Kruse AJ, van Diermen B, Janssen EA, Skaland I, Gudlaugsson E, Nilsen ST, Baak JP.

APMIS. 2007 Dec;115(12):1409-14. doi: 10.1111/j.1600-0463.2007.00769.x.

PMID:
18184413
15.

Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2.

Okadome M, Saito T, Tanaka H, Nogawa T, Furuta R, Watanabe K, Kita T, Yamamoto K, Mikami M, Takizawa K; Japanese Gynecologic Oncology Group (JGOG).

J Obstet Gynaecol Res. 2014 Feb;40(2):561-9. doi: 10.1111/jog.12202. Epub 2013 Oct 22.

PMID:
24147758
16.

Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3.

Syrjänen K, Shabalova I, Naud P, Derchain S, Sarian L, Kozachenko V, Zakharchenko S, Roteli-Martins C, Nerovjna R, Longatto-Filho A, Kljukina L, Tatti S, Branovskaja M, Branca M, Grunjberga V, Erzen M, Juschenko A, Hammes LS, Costa S, Podistov J, Syrjänen S; NIS and the LAMS Study Research Groups; Analysis of the combined prospective cohort of the NIS; LAMS Studies.

Int J STD AIDS. 2011 May;22(5):263-72. doi: 10.1258/ijsa.2009.009280.

PMID:
21571974
17.

p16(INK4a) Expression does not predict the outcome of cervical intraepithelial neoplasia grade 2.

Guedes AC, Brenna SM, Coelho SA, Martinez EZ, Syrjänen KJ, Zeferino LC.

Int J Gynecol Cancer. 2007 Sep-Oct;17(5):1099-103. Epub 2007 Mar 15.

PMID:
17367324
18.

[Diagnosis of cervical intraepithelial neoplasia by visual inspection with acetic acid among Chinese women: a meta-analysis].

Wei LX, Zhang K, Yang L, Guo LW, Chen YH, Li Q, Dai M, Li N.

Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jan;46(1):70-5. Chinese.

PMID:
22490145
19.

Clinical determinants of a positive visual inspection after treatment with acetic acid for cervical cancer screening.

Castle PE, Qiao YL, Zhao FH, Chen W, Valdez M, Zhang X, Kang LN, Bansil P, Paul P, Bai P, Peck R, Li J, Chen F, Jeronimo J.

BJOG. 2014 May;121(6):739-46. doi: 10.1111/1471-0528.12646. Epub 2014 Feb 28.

20.

Risk stratification by p16 immunostaining of CIN1 biopsies: a retrospective study of patients from the quadrivalent HPV vaccine trials.

Mills AM, Paquette C, Castle PE, Stoler MH.

Am J Surg Pathol. 2015 May;39(5):611-7. doi: 10.1097/PAS.0000000000000374.

PMID:
25602791
Items per page

Supplemental Content

Write to the Help Desk